HomeClinical TopicsFDA approves head lice treatment

FDA approves head lice treatment

Author(s):

The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4 years and older. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240302.htm.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...